ARHGEF12 and urinary bladder carcinoma: Furthermore, integrating scRNA sequencing with multi-omics bioinformatics of TCGA and GTEx data, this study identifies ARHGEF12 as a key regulator of cisplatin resistance in BLCA for the first time, opening new avenues and potential targets for elucidating mechanisms of cisplatin resistance in bladder cancer.